产品信息
参考资料(来源文献)
| 背景描述 | HCC38 BL is a B lymphoblastoid cell line initiated by Epstein-Barr virus (EBV) transformation of peripheral blood lymphocytes obtained from the same patient as HCC38. HCC38 was initiated from a 50-year-old white female with primary breast ductal carcinoma and a prior history of leiomyosarcoma; her mother died of breast cancer. |
| 年龄（性别） | 女性；50岁 |
| 组织来源 | 外周血 |
| 细胞类型 | 转化细胞系 |
| 生物安全等级 | BSL-2 |
| 倍增时间 | 48-60hours |
| 保藏机构 | ATCC; CRL-2346 |
FAQs
Q：{{item.question}}
A：
暂无数据
